Title : Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.

Pub. Date : 2018 Oct 27

PMID : 30368448






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVES: Budesonide/formoterol (BF) Spiromax is an inhaled corticosteroid/long-acting beta2-agonist fixed-dose combination (FDC) inhaler, designed to minimise common inhaler errors and provide reliable and consistent dose delivery in asthma and chronic obstructive pulmonary disease (COPD). Budesonide potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens